2009
DOI: 10.1111/j.1365-2710.2008.00988.x
|View full text |Cite
|
Sign up to set email alerts
|

A prospective study evaluating clinical outcomes and costs of three NNRTI-based HAART regimens in Kerala, India

Abstract: Provision of free NNRTI-based combination therapy to patients in Kerala, India, resulted in greater than 90% adherence leading to better clinical outcomes in terms of increasing CD4 counts and low mortality, for patients consistently attending a treatment clinic.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
16
0

Year Published

2010
2010
2020
2020

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 11 publications
(16 citation statements)
references
References 32 publications
0
16
0
Order By: Relevance
“…There were seven cross-sectional studies(11122122232425) and one retrospective chart analyses. (26) Three studies were conducted in southern India(212426) and two each in western(1225) and north India. (2223) One study enrolled participants from western and northern India.…”
Section: Resultsmentioning
confidence: 99%
See 3 more Smart Citations
“…There were seven cross-sectional studies(11122122232425) and one retrospective chart analyses. (26) Three studies were conducted in southern India(212426) and two each in western(1225) and north India. (2223) One study enrolled participants from western and northern India.…”
Section: Resultsmentioning
confidence: 99%
“…Seventy-five percent (6/8) of the studies reported the recall period. (112122242526) The length of recall period varied from previous 4 days to lifetime recall [Table 2]. …”
Section: Resultsmentioning
confidence: 99%
See 2 more Smart Citations
“…Institutional factors are also important to emphasize, since free access to HAART and uninterrupted supply have proven to be crucial to achieve and maintain good levels of adherence in resource-constrained settings. 6,16,17 In a 12-month study conducted to evaluate the impact of a similar intervention on a comparable group of 96 patients at the University Hospital of Casablanca, Marchand et al found a baseline adherence score of 0.7, which improved at M3, amounting to 0.87, and to 0.91 at M12. 18 In another resource-limited setting at Jos University Hospital in Nigeria, Abah et al examined the impact of a program to support adherence among 121 patients recently enrolled in the HarvardPepfar HAART initiative and showed that the proportion of patients who had an adherence level superior to 95% increased from 79.4% of the cohort at the beginning of the study, to 92.4% at the end.…”
Section: Discussionmentioning
confidence: 99%